JOURNAL OF CELLULAR AND MOLECULAR MEDICINE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1075988, encodeId=1f6010e5988fb, content=偏重的研究方向：细胞生物学 经验分享：有没有9月投稿的小伙伴, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e55679937, createdName=ms5000001105610949, createdTime=Wed Dec 01 20:46:13 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054459, encodeId=36fd1054459fe, content=偏重的研究方向：分子生物学;干细胞;成骨分化 经验分享：刚投了一篇给大家一点参考意见一审大概两个半月大修四个审稿人一个比较水三个很认真态度还算友好给了两个月的补实验时间修回去以后第八天说要原始数据两天后给过去原始数据一周后接受总的加起来4个多月我的实验数据量还算可以创新性还行但是机制做的不是很深入体内外实验都有大概4-5分文章的水平给大家参考下祝大家实验和文章都顺利 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee0e5503366, createdName=sanyah, createdTime=Fri Sep 24 14:43:18 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905385, encodeId=6d4690538580, content=上了中山大学一附院不予报销杂志名单，意思就是黑名单水刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dcf1972913, createdName=填写后不可修改, createdTime=Sun Dec 06 12:11:02 CST 2020, time=2020-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885505, encodeId=731c88550507, content=都投进去半年了，一直在审稿中，审个稿那么慢吗？审稿专家不是有截止日期吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200805/fe2680c295f74c7a8e5319e11dbb8b39/afe0205d68974149ad3f5085f9b6408a.jpg, createdBy=80972258745, createdName=**爱豆, createdTime=Tue Sep 15 16:27:20 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802577, encodeId=8e188025e7d2, content=求问：有人成功申请过修稿时间延长吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44b15326055, createdName=178Ob6, createdTime=Sun Jul 12 10:39:07 CST 2020, time=2020-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161086, encodeId=d35c216108662, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：一次大修一次小修，六个月接收，版面排到半年后。。。急着用，能不能催啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffd26150764, createdName=ms5000002112458054, createdTime=Thu Oct 05 21:50:10 CST 2023, time=2023-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1081948, encodeId=7419108194804, content=从under review，到Awaiting ED Recommendation，现在到Awaiting EIC Decision，好紧张啊，天哪，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Mon Dec 20 00:35:53 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974932, encodeId=c5ef9e493228, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：基础医学;心血管 经验分享：这个杂志要求提供原始数据，大家怎么处理的呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=28445529202, createdName=gggg11, createdTime=Sat Jun 19 18:52:16 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896944, encodeId=2d8d89694471, content=三审两个月了，要不要催一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acbe2092313, createdName=Aslan1, createdTime=Wed Nov 04 21:11:33 CST 2020, time=2020-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918304, encodeId=82e8918304f3, content=审稿速度:6.0 经验分享：5个月了。说没有合适审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJTmMxTe2RXNXFfKMKwWyozlWyF5rocaElz8YrOepiaZBiczq2gCUVB391362fROIypNLFWqMv1Q9mA/132, createdBy=dddd2353500, createdName=小晓医, createdTime=Wed Jan 20 10:21:33 CST 2021, time=2021-01-20, status=1, ipAttribution=)]

2021-12-01 ms5000001105610949

偏重的研究方向：细胞生物学
经验分享：有没有9月投稿的小伙伴

47 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=1075988, encodeId=1f6010e5988fb, content=偏重的研究方向：细胞生物学 经验分享：有没有9月投稿的小伙伴, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e55679937, createdName=ms5000001105610949, createdTime=Wed Dec 01 20:46:13 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054459, encodeId=36fd1054459fe, content=偏重的研究方向：分子生物学;干细胞;成骨分化 经验分享：刚投了一篇给大家一点参考意见一审大概两个半月大修四个审稿人一个比较水三个很认真态度还算友好给了两个月的补实验时间修回去以后第八天说要原始数据两天后给过去原始数据一周后接受总的加起来4个多月我的实验数据量还算可以创新性还行但是机制做的不是很深入体内外实验都有大概4-5分文章的水平给大家参考下祝大家实验和文章都顺利 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee0e5503366, createdName=sanyah, createdTime=Fri Sep 24 14:43:18 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905385, encodeId=6d4690538580, content=上了中山大学一附院不予报销杂志名单，意思就是黑名单水刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dcf1972913, createdName=填写后不可修改, createdTime=Sun Dec 06 12:11:02 CST 2020, time=2020-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885505, encodeId=731c88550507, content=都投进去半年了，一直在审稿中，审个稿那么慢吗？审稿专家不是有截止日期吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200805/fe2680c295f74c7a8e5319e11dbb8b39/afe0205d68974149ad3f5085f9b6408a.jpg, createdBy=80972258745, createdName=**爱豆, createdTime=Tue Sep 15 16:27:20 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802577, encodeId=8e188025e7d2, content=求问：有人成功申请过修稿时间延长吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44b15326055, createdName=178Ob6, createdTime=Sun Jul 12 10:39:07 CST 2020, time=2020-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161086, encodeId=d35c216108662, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：一次大修一次小修，六个月接收，版面排到半年后。。。急着用，能不能催啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffd26150764, createdName=ms5000002112458054, createdTime=Thu Oct 05 21:50:10 CST 2023, time=2023-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1081948, encodeId=7419108194804, content=从under review，到Awaiting ED Recommendation，现在到Awaiting EIC Decision，好紧张啊，天哪，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Mon Dec 20 00:35:53 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974932, encodeId=c5ef9e493228, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：基础医学;心血管 经验分享：这个杂志要求提供原始数据，大家怎么处理的呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=28445529202, createdName=gggg11, createdTime=Sat Jun 19 18:52:16 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896944, encodeId=2d8d89694471, content=三审两个月了，要不要催一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acbe2092313, createdName=Aslan1, createdTime=Wed Nov 04 21:11:33 CST 2020, time=2020-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918304, encodeId=82e8918304f3, content=审稿速度:6.0 经验分享：5个月了。说没有合适审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJTmMxTe2RXNXFfKMKwWyozlWyF5rocaElz8YrOepiaZBiczq2gCUVB391362fROIypNLFWqMv1Q9mA/132, createdBy=dddd2353500, createdName=小晓医, createdTime=Wed Jan 20 10:21:33 CST 2021, time=2021-01-20, status=1, ipAttribution=)]

2021-09-24 sanyah

偏重的研究方向：分子生物学;干细胞;成骨分化
经验分享：刚投了一篇给大家一点参考意见一审大概两个半月大修四个审稿人一个比较水三个很认真态度还算友好给了两个月的补实验时间修回去以后第八天说要原始数据两天后给过去原始数据一周后接受总的加起来4个多月我的实验数据量还算可以创新性还行但是机制做的不是很深入体内外实验都有大概4-5分文章的水平给大家参考下祝大家实验和文章都顺利

56 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=1075988, encodeId=1f6010e5988fb, content=偏重的研究方向：细胞生物学 经验分享：有没有9月投稿的小伙伴, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e55679937, createdName=ms5000001105610949, createdTime=Wed Dec 01 20:46:13 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054459, encodeId=36fd1054459fe, content=偏重的研究方向：分子生物学;干细胞;成骨分化 经验分享：刚投了一篇给大家一点参考意见一审大概两个半月大修四个审稿人一个比较水三个很认真态度还算友好给了两个月的补实验时间修回去以后第八天说要原始数据两天后给过去原始数据一周后接受总的加起来4个多月我的实验数据量还算可以创新性还行但是机制做的不是很深入体内外实验都有大概4-5分文章的水平给大家参考下祝大家实验和文章都顺利 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee0e5503366, createdName=sanyah, createdTime=Fri Sep 24 14:43:18 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905385, encodeId=6d4690538580, content=上了中山大学一附院不予报销杂志名单，意思就是黑名单水刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dcf1972913, createdName=填写后不可修改, createdTime=Sun Dec 06 12:11:02 CST 2020, time=2020-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885505, encodeId=731c88550507, content=都投进去半年了，一直在审稿中，审个稿那么慢吗？审稿专家不是有截止日期吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200805/fe2680c295f74c7a8e5319e11dbb8b39/afe0205d68974149ad3f5085f9b6408a.jpg, createdBy=80972258745, createdName=**爱豆, createdTime=Tue Sep 15 16:27:20 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802577, encodeId=8e188025e7d2, content=求问：有人成功申请过修稿时间延长吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44b15326055, createdName=178Ob6, createdTime=Sun Jul 12 10:39:07 CST 2020, time=2020-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161086, encodeId=d35c216108662, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：一次大修一次小修，六个月接收，版面排到半年后。。。急着用，能不能催啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffd26150764, createdName=ms5000002112458054, createdTime=Thu Oct 05 21:50:10 CST 2023, time=2023-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1081948, encodeId=7419108194804, content=从under review，到Awaiting ED Recommendation，现在到Awaiting EIC Decision，好紧张啊，天哪，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Mon Dec 20 00:35:53 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974932, encodeId=c5ef9e493228, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：基础医学;心血管 经验分享：这个杂志要求提供原始数据，大家怎么处理的呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=28445529202, createdName=gggg11, createdTime=Sat Jun 19 18:52:16 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896944, encodeId=2d8d89694471, content=三审两个月了，要不要催一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acbe2092313, createdName=Aslan1, createdTime=Wed Nov 04 21:11:33 CST 2020, time=2020-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918304, encodeId=82e8918304f3, content=审稿速度:6.0 经验分享：5个月了。说没有合适审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJTmMxTe2RXNXFfKMKwWyozlWyF5rocaElz8YrOepiaZBiczq2gCUVB391362fROIypNLFWqMv1Q9mA/132, createdBy=dddd2353500, createdName=小晓医, createdTime=Wed Jan 20 10:21:33 CST 2021, time=2021-01-20, status=1, ipAttribution=)]

2020-12-06 填写后不可修改

上了中山大学一附院不予报销杂志名单，意思就是黑名单水刊

606 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=1075988, encodeId=1f6010e5988fb, content=偏重的研究方向：细胞生物学 经验分享：有没有9月投稿的小伙伴, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e55679937, createdName=ms5000001105610949, createdTime=Wed Dec 01 20:46:13 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054459, encodeId=36fd1054459fe, content=偏重的研究方向：分子生物学;干细胞;成骨分化 经验分享：刚投了一篇给大家一点参考意见一审大概两个半月大修四个审稿人一个比较水三个很认真态度还算友好给了两个月的补实验时间修回去以后第八天说要原始数据两天后给过去原始数据一周后接受总的加起来4个多月我的实验数据量还算可以创新性还行但是机制做的不是很深入体内外实验都有大概4-5分文章的水平给大家参考下祝大家实验和文章都顺利 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee0e5503366, createdName=sanyah, createdTime=Fri Sep 24 14:43:18 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905385, encodeId=6d4690538580, content=上了中山大学一附院不予报销杂志名单，意思就是黑名单水刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dcf1972913, createdName=填写后不可修改, createdTime=Sun Dec 06 12:11:02 CST 2020, time=2020-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885505, encodeId=731c88550507, content=都投进去半年了，一直在审稿中，审个稿那么慢吗？审稿专家不是有截止日期吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200805/fe2680c295f74c7a8e5319e11dbb8b39/afe0205d68974149ad3f5085f9b6408a.jpg, createdBy=80972258745, createdName=**爱豆, createdTime=Tue Sep 15 16:27:20 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802577, encodeId=8e188025e7d2, content=求问：有人成功申请过修稿时间延长吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44b15326055, createdName=178Ob6, createdTime=Sun Jul 12 10:39:07 CST 2020, time=2020-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161086, encodeId=d35c216108662, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：一次大修一次小修，六个月接收，版面排到半年后。。。急着用，能不能催啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffd26150764, createdName=ms5000002112458054, createdTime=Thu Oct 05 21:50:10 CST 2023, time=2023-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1081948, encodeId=7419108194804, content=从under review，到Awaiting ED Recommendation，现在到Awaiting EIC Decision，好紧张啊，天哪，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Mon Dec 20 00:35:53 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974932, encodeId=c5ef9e493228, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：基础医学;心血管 经验分享：这个杂志要求提供原始数据，大家怎么处理的呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=28445529202, createdName=gggg11, createdTime=Sat Jun 19 18:52:16 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896944, encodeId=2d8d89694471, content=三审两个月了，要不要催一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acbe2092313, createdName=Aslan1, createdTime=Wed Nov 04 21:11:33 CST 2020, time=2020-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918304, encodeId=82e8918304f3, content=审稿速度:6.0 经验分享：5个月了。说没有合适审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJTmMxTe2RXNXFfKMKwWyozlWyF5rocaElz8YrOepiaZBiczq2gCUVB391362fROIypNLFWqMv1Q9mA/132, createdBy=dddd2353500, createdName=小晓医, createdTime=Wed Jan 20 10:21:33 CST 2021, time=2021-01-20, status=1, ipAttribution=)]

2020-09-15 **爱豆

都投进去半年了，一直在审稿中，审个稿那么慢吗？审稿专家不是有截止日期吗

151 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=1075988, encodeId=1f6010e5988fb, content=偏重的研究方向：细胞生物学 经验分享：有没有9月投稿的小伙伴, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e55679937, createdName=ms5000001105610949, createdTime=Wed Dec 01 20:46:13 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054459, encodeId=36fd1054459fe, content=偏重的研究方向：分子生物学;干细胞;成骨分化 经验分享：刚投了一篇给大家一点参考意见一审大概两个半月大修四个审稿人一个比较水三个很认真态度还算友好给了两个月的补实验时间修回去以后第八天说要原始数据两天后给过去原始数据一周后接受总的加起来4个多月我的实验数据量还算可以创新性还行但是机制做的不是很深入体内外实验都有大概4-5分文章的水平给大家参考下祝大家实验和文章都顺利 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee0e5503366, createdName=sanyah, createdTime=Fri Sep 24 14:43:18 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905385, encodeId=6d4690538580, content=上了中山大学一附院不予报销杂志名单，意思就是黑名单水刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dcf1972913, createdName=填写后不可修改, createdTime=Sun Dec 06 12:11:02 CST 2020, time=2020-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885505, encodeId=731c88550507, content=都投进去半年了，一直在审稿中，审个稿那么慢吗？审稿专家不是有截止日期吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200805/fe2680c295f74c7a8e5319e11dbb8b39/afe0205d68974149ad3f5085f9b6408a.jpg, createdBy=80972258745, createdName=**爱豆, createdTime=Tue Sep 15 16:27:20 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802577, encodeId=8e188025e7d2, content=求问：有人成功申请过修稿时间延长吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44b15326055, createdName=178Ob6, createdTime=Sun Jul 12 10:39:07 CST 2020, time=2020-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161086, encodeId=d35c216108662, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：一次大修一次小修，六个月接收，版面排到半年后。。。急着用，能不能催啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffd26150764, createdName=ms5000002112458054, createdTime=Thu Oct 05 21:50:10 CST 2023, time=2023-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1081948, encodeId=7419108194804, content=从under review，到Awaiting ED Recommendation，现在到Awaiting EIC Decision，好紧张啊，天哪，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Mon Dec 20 00:35:53 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974932, encodeId=c5ef9e493228, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：基础医学;心血管 经验分享：这个杂志要求提供原始数据，大家怎么处理的呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=28445529202, createdName=gggg11, createdTime=Sat Jun 19 18:52:16 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896944, encodeId=2d8d89694471, content=三审两个月了，要不要催一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acbe2092313, createdName=Aslan1, createdTime=Wed Nov 04 21:11:33 CST 2020, time=2020-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918304, encodeId=82e8918304f3, content=审稿速度:6.0 经验分享：5个月了。说没有合适审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJTmMxTe2RXNXFfKMKwWyozlWyF5rocaElz8YrOepiaZBiczq2gCUVB391362fROIypNLFWqMv1Q9mA/132, createdBy=dddd2353500, createdName=小晓医, createdTime=Wed Jan 20 10:21:33 CST 2021, time=2021-01-20, status=1, ipAttribution=)]

2020-07-12 178Ob6

求问：有人成功申请过修稿时间延长吗？

127 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=1075988, encodeId=1f6010e5988fb, content=偏重的研究方向：细胞生物学 经验分享：有没有9月投稿的小伙伴, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e55679937, createdName=ms5000001105610949, createdTime=Wed Dec 01 20:46:13 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054459, encodeId=36fd1054459fe, content=偏重的研究方向：分子生物学;干细胞;成骨分化 经验分享：刚投了一篇给大家一点参考意见一审大概两个半月大修四个审稿人一个比较水三个很认真态度还算友好给了两个月的补实验时间修回去以后第八天说要原始数据两天后给过去原始数据一周后接受总的加起来4个多月我的实验数据量还算可以创新性还行但是机制做的不是很深入体内外实验都有大概4-5分文章的水平给大家参考下祝大家实验和文章都顺利 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee0e5503366, createdName=sanyah, createdTime=Fri Sep 24 14:43:18 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905385, encodeId=6d4690538580, content=上了中山大学一附院不予报销杂志名单，意思就是黑名单水刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dcf1972913, createdName=填写后不可修改, createdTime=Sun Dec 06 12:11:02 CST 2020, time=2020-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885505, encodeId=731c88550507, content=都投进去半年了，一直在审稿中，审个稿那么慢吗？审稿专家不是有截止日期吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200805/fe2680c295f74c7a8e5319e11dbb8b39/afe0205d68974149ad3f5085f9b6408a.jpg, createdBy=80972258745, createdName=**爱豆, createdTime=Tue Sep 15 16:27:20 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802577, encodeId=8e188025e7d2, content=求问：有人成功申请过修稿时间延长吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44b15326055, createdName=178Ob6, createdTime=Sun Jul 12 10:39:07 CST 2020, time=2020-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161086, encodeId=d35c216108662, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：一次大修一次小修，六个月接收，版面排到半年后。。。急着用，能不能催啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffd26150764, createdName=ms5000002112458054, createdTime=Thu Oct 05 21:50:10 CST 2023, time=2023-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1081948, encodeId=7419108194804, content=从under review，到Awaiting ED Recommendation，现在到Awaiting EIC Decision，好紧张啊，天哪，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Mon Dec 20 00:35:53 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974932, encodeId=c5ef9e493228, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：基础医学;心血管 经验分享：这个杂志要求提供原始数据，大家怎么处理的呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=28445529202, createdName=gggg11, createdTime=Sat Jun 19 18:52:16 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896944, encodeId=2d8d89694471, content=三审两个月了，要不要催一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acbe2092313, createdName=Aslan1, createdTime=Wed Nov 04 21:11:33 CST 2020, time=2020-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918304, encodeId=82e8918304f3, content=审稿速度:6.0 经验分享：5个月了。说没有合适审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJTmMxTe2RXNXFfKMKwWyozlWyF5rocaElz8YrOepiaZBiczq2gCUVB391362fROIypNLFWqMv1Q9mA/132, createdBy=dddd2353500, createdName=小晓医, createdTime=Wed Jan 20 10:21:33 CST 2021, time=2021-01-20, status=1, ipAttribution=)]

2023-10-05 ms5000002112458054 来自广东省

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：免疫;炎症
经验分享：一次大修一次小修，六个月接收，版面排到半年后。。。急着用，能不能催啊...

31 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=1075988, encodeId=1f6010e5988fb, content=偏重的研究方向：细胞生物学 经验分享：有没有9月投稿的小伙伴, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e55679937, createdName=ms5000001105610949, createdTime=Wed Dec 01 20:46:13 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054459, encodeId=36fd1054459fe, content=偏重的研究方向：分子生物学;干细胞;成骨分化 经验分享：刚投了一篇给大家一点参考意见一审大概两个半月大修四个审稿人一个比较水三个很认真态度还算友好给了两个月的补实验时间修回去以后第八天说要原始数据两天后给过去原始数据一周后接受总的加起来4个多月我的实验数据量还算可以创新性还行但是机制做的不是很深入体内外实验都有大概4-5分文章的水平给大家参考下祝大家实验和文章都顺利 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee0e5503366, createdName=sanyah, createdTime=Fri Sep 24 14:43:18 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905385, encodeId=6d4690538580, content=上了中山大学一附院不予报销杂志名单，意思就是黑名单水刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dcf1972913, createdName=填写后不可修改, createdTime=Sun Dec 06 12:11:02 CST 2020, time=2020-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885505, encodeId=731c88550507, content=都投进去半年了，一直在审稿中，审个稿那么慢吗？审稿专家不是有截止日期吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200805/fe2680c295f74c7a8e5319e11dbb8b39/afe0205d68974149ad3f5085f9b6408a.jpg, createdBy=80972258745, createdName=**爱豆, createdTime=Tue Sep 15 16:27:20 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802577, encodeId=8e188025e7d2, content=求问：有人成功申请过修稿时间延长吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44b15326055, createdName=178Ob6, createdTime=Sun Jul 12 10:39:07 CST 2020, time=2020-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161086, encodeId=d35c216108662, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：一次大修一次小修，六个月接收，版面排到半年后。。。急着用，能不能催啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffd26150764, createdName=ms5000002112458054, createdTime=Thu Oct 05 21:50:10 CST 2023, time=2023-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1081948, encodeId=7419108194804, content=从under review，到Awaiting ED Recommendation，现在到Awaiting EIC Decision，好紧张啊，天哪，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Mon Dec 20 00:35:53 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974932, encodeId=c5ef9e493228, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：基础医学;心血管 经验分享：这个杂志要求提供原始数据，大家怎么处理的呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=28445529202, createdName=gggg11, createdTime=Sat Jun 19 18:52:16 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896944, encodeId=2d8d89694471, content=三审两个月了，要不要催一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acbe2092313, createdName=Aslan1, createdTime=Wed Nov 04 21:11:33 CST 2020, time=2020-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918304, encodeId=82e8918304f3, content=审稿速度:6.0 经验分享：5个月了。说没有合适审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJTmMxTe2RXNXFfKMKwWyozlWyF5rocaElz8YrOepiaZBiczq2gCUVB391362fROIypNLFWqMv1Q9mA/132, createdBy=dddd2353500, createdName=小晓医, createdTime=Wed Jan 20 10:21:33 CST 2021, time=2021-01-20, status=1, ipAttribution=)]

2021-12-20 916603706

从under review，到Awaiting ED Recommendation，现在到Awaiting EIC Decision，好紧张啊，天哪，

0 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=1075988, encodeId=1f6010e5988fb, content=偏重的研究方向：细胞生物学 经验分享：有没有9月投稿的小伙伴, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e55679937, createdName=ms5000001105610949, createdTime=Wed Dec 01 20:46:13 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054459, encodeId=36fd1054459fe, content=偏重的研究方向：分子生物学;干细胞;成骨分化 经验分享：刚投了一篇给大家一点参考意见一审大概两个半月大修四个审稿人一个比较水三个很认真态度还算友好给了两个月的补实验时间修回去以后第八天说要原始数据两天后给过去原始数据一周后接受总的加起来4个多月我的实验数据量还算可以创新性还行但是机制做的不是很深入体内外实验都有大概4-5分文章的水平给大家参考下祝大家实验和文章都顺利 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee0e5503366, createdName=sanyah, createdTime=Fri Sep 24 14:43:18 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905385, encodeId=6d4690538580, content=上了中山大学一附院不予报销杂志名单，意思就是黑名单水刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dcf1972913, createdName=填写后不可修改, createdTime=Sun Dec 06 12:11:02 CST 2020, time=2020-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885505, encodeId=731c88550507, content=都投进去半年了，一直在审稿中，审个稿那么慢吗？审稿专家不是有截止日期吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200805/fe2680c295f74c7a8e5319e11dbb8b39/afe0205d68974149ad3f5085f9b6408a.jpg, createdBy=80972258745, createdName=**爱豆, createdTime=Tue Sep 15 16:27:20 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802577, encodeId=8e188025e7d2, content=求问：有人成功申请过修稿时间延长吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44b15326055, createdName=178Ob6, createdTime=Sun Jul 12 10:39:07 CST 2020, time=2020-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161086, encodeId=d35c216108662, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：一次大修一次小修，六个月接收，版面排到半年后。。。急着用，能不能催啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffd26150764, createdName=ms5000002112458054, createdTime=Thu Oct 05 21:50:10 CST 2023, time=2023-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1081948, encodeId=7419108194804, content=从under review，到Awaiting ED Recommendation，现在到Awaiting EIC Decision，好紧张啊，天哪，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Mon Dec 20 00:35:53 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974932, encodeId=c5ef9e493228, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：基础医学;心血管 经验分享：这个杂志要求提供原始数据，大家怎么处理的呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=28445529202, createdName=gggg11, createdTime=Sat Jun 19 18:52:16 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896944, encodeId=2d8d89694471, content=三审两个月了，要不要催一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acbe2092313, createdName=Aslan1, createdTime=Wed Nov 04 21:11:33 CST 2020, time=2020-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918304, encodeId=82e8918304f3, content=审稿速度:6.0 经验分享：5个月了。说没有合适审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJTmMxTe2RXNXFfKMKwWyozlWyF5rocaElz8YrOepiaZBiczq2gCUVB391362fROIypNLFWqMv1Q9mA/132, createdBy=dddd2353500, createdName=小晓医, createdTime=Wed Jan 20 10:21:33 CST 2021, time=2021-01-20, status=1, ipAttribution=)]

2021-06-19 gggg11

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：基础医学;心血管
经验分享：这个杂志要求提供原始数据，大家怎么处理的呢

38 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=1075988, encodeId=1f6010e5988fb, content=偏重的研究方向：细胞生物学 经验分享：有没有9月投稿的小伙伴, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e55679937, createdName=ms5000001105610949, createdTime=Wed Dec 01 20:46:13 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054459, encodeId=36fd1054459fe, content=偏重的研究方向：分子生物学;干细胞;成骨分化 经验分享：刚投了一篇给大家一点参考意见一审大概两个半月大修四个审稿人一个比较水三个很认真态度还算友好给了两个月的补实验时间修回去以后第八天说要原始数据两天后给过去原始数据一周后接受总的加起来4个多月我的实验数据量还算可以创新性还行但是机制做的不是很深入体内外实验都有大概4-5分文章的水平给大家参考下祝大家实验和文章都顺利 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee0e5503366, createdName=sanyah, createdTime=Fri Sep 24 14:43:18 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905385, encodeId=6d4690538580, content=上了中山大学一附院不予报销杂志名单，意思就是黑名单水刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dcf1972913, createdName=填写后不可修改, createdTime=Sun Dec 06 12:11:02 CST 2020, time=2020-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885505, encodeId=731c88550507, content=都投进去半年了，一直在审稿中，审个稿那么慢吗？审稿专家不是有截止日期吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200805/fe2680c295f74c7a8e5319e11dbb8b39/afe0205d68974149ad3f5085f9b6408a.jpg, createdBy=80972258745, createdName=**爱豆, createdTime=Tue Sep 15 16:27:20 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802577, encodeId=8e188025e7d2, content=求问：有人成功申请过修稿时间延长吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44b15326055, createdName=178Ob6, createdTime=Sun Jul 12 10:39:07 CST 2020, time=2020-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161086, encodeId=d35c216108662, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：一次大修一次小修，六个月接收，版面排到半年后。。。急着用，能不能催啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffd26150764, createdName=ms5000002112458054, createdTime=Thu Oct 05 21:50:10 CST 2023, time=2023-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1081948, encodeId=7419108194804, content=从under review，到Awaiting ED Recommendation，现在到Awaiting EIC Decision，好紧张啊，天哪，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Mon Dec 20 00:35:53 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974932, encodeId=c5ef9e493228, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：基础医学;心血管 经验分享：这个杂志要求提供原始数据，大家怎么处理的呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=28445529202, createdName=gggg11, createdTime=Sat Jun 19 18:52:16 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896944, encodeId=2d8d89694471, content=三审两个月了，要不要催一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acbe2092313, createdName=Aslan1, createdTime=Wed Nov 04 21:11:33 CST 2020, time=2020-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918304, encodeId=82e8918304f3, content=审稿速度:6.0 经验分享：5个月了。说没有合适审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJTmMxTe2RXNXFfKMKwWyozlWyF5rocaElz8YrOepiaZBiczq2gCUVB391362fROIypNLFWqMv1Q9mA/132, createdBy=dddd2353500, createdName=小晓医, createdTime=Wed Jan 20 10:21:33 CST 2021, time=2021-01-20, status=1, ipAttribution=)]

2020-11-04 Aslan1

三审两个月了，要不要催一下？

124 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=1075988, encodeId=1f6010e5988fb, content=偏重的研究方向：细胞生物学 经验分享：有没有9月投稿的小伙伴, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e55679937, createdName=ms5000001105610949, createdTime=Wed Dec 01 20:46:13 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054459, encodeId=36fd1054459fe, content=偏重的研究方向：分子生物学;干细胞;成骨分化 经验分享：刚投了一篇给大家一点参考意见一审大概两个半月大修四个审稿人一个比较水三个很认真态度还算友好给了两个月的补实验时间修回去以后第八天说要原始数据两天后给过去原始数据一周后接受总的加起来4个多月我的实验数据量还算可以创新性还行但是机制做的不是很深入体内外实验都有大概4-5分文章的水平给大家参考下祝大家实验和文章都顺利 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee0e5503366, createdName=sanyah, createdTime=Fri Sep 24 14:43:18 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905385, encodeId=6d4690538580, content=上了中山大学一附院不予报销杂志名单，意思就是黑名单水刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dcf1972913, createdName=填写后不可修改, createdTime=Sun Dec 06 12:11:02 CST 2020, time=2020-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885505, encodeId=731c88550507, content=都投进去半年了，一直在审稿中，审个稿那么慢吗？审稿专家不是有截止日期吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200805/fe2680c295f74c7a8e5319e11dbb8b39/afe0205d68974149ad3f5085f9b6408a.jpg, createdBy=80972258745, createdName=**爱豆, createdTime=Tue Sep 15 16:27:20 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802577, encodeId=8e188025e7d2, content=求问：有人成功申请过修稿时间延长吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44b15326055, createdName=178Ob6, createdTime=Sun Jul 12 10:39:07 CST 2020, time=2020-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161086, encodeId=d35c216108662, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：一次大修一次小修，六个月接收，版面排到半年后。。。急着用，能不能催啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffd26150764, createdName=ms5000002112458054, createdTime=Thu Oct 05 21:50:10 CST 2023, time=2023-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1081948, encodeId=7419108194804, content=从under review，到Awaiting ED Recommendation，现在到Awaiting EIC Decision，好紧张啊，天哪，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Mon Dec 20 00:35:53 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974932, encodeId=c5ef9e493228, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：基础医学;心血管 经验分享：这个杂志要求提供原始数据，大家怎么处理的呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=28445529202, createdName=gggg11, createdTime=Sat Jun 19 18:52:16 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896944, encodeId=2d8d89694471, content=三审两个月了，要不要催一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acbe2092313, createdName=Aslan1, createdTime=Wed Nov 04 21:11:33 CST 2020, time=2020-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918304, encodeId=82e8918304f3, content=审稿速度:6.0 经验分享：5个月了。说没有合适审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJTmMxTe2RXNXFfKMKwWyozlWyF5rocaElz8YrOepiaZBiczq2gCUVB391362fROIypNLFWqMv1Q9mA/132, createdBy=dddd2353500, createdName=小晓医, createdTime=Wed Jan 20 10:21:33 CST 2021, time=2021-01-20, status=1, ipAttribution=)]

2021-01-20 小晓医

审稿速度:6.0
经验分享：5个月了。说没有合适审稿人

78 6

展开6条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务